Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02213523 · ClinicalTrials.gov registry record · NA
ABG Oxidative Stress Study Protocol-1
A NA study, sponsored by Access Business Group.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02213523: Completed NA study, sponsored by Access Business Group.
NCT02213523 is a NA study that has completed, run by Access Business Group. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02213523, a NA study, has completed, sponsored by Access Business Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a proof of concept study that evaluates the response to oxidative stress in healthy men after taking plant concentrates.
Interventions
- DIETARY_SUPPLEMENT Plant concentrate A
- DIETARY_SUPPLEMENT Plant concentrate B
- DIETARY_SUPPLEMENT Plant concentrate C
- DIETARY_SUPPLEMENT Plant concentrate D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02213523
The ClinicalTrials.gov registry entry for NCT02213523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Access Business Group, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Plant concentrate A is the first listed.
NCT02213523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02213523 about?
NCT02213523 is a clinical study titled "ABG Oxidative Stress Study Protocol-1". This is a proof of concept study that evaluates the response to oxidative stress in healthy men after taking plant concentrates.
What is the current status of trial NCT02213523?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02213523?
The interventions under investigation include: Plant concentrate A (DIETARY_SUPPLEMENT), Plant concentrate B (DIETARY_SUPPLEMENT), Plant concentrate C (DIETARY_SUPPLEMENT), Plant concentrate D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02213523?
This trial is sponsored by Access Business Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.